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The COVID-19 has disrupted health systems, even within the most developed economies, with case fatality rates in certain countries exceeding 10% [1].
COVID-19 deaths have been linked to diabetes and hypertension [2], 
which also correlate with obesity. As adipose tissue is prone to infec-
tion by the virus and produces high levels of inflammatory cytokines 
[3], it may feed the cytokine storm [4] suffered by many COVID-19 
fatalities suggesting obesity could be the key factor.
COVID-19 nation death rates vary greatly, but countries with low obe-
sity rates have consistently low fatality rates; specifically, Thailand, Chi-
na, South Korea, Japan and Pakistan are all countries of over 10 million 
population, but with a national obesity rate of 10% or less [5], which all have less than 50 deaths per mil-
lion [1]. There are clearly a multitude of factors that contribute to the national death rates. However, coun-
tries with obesity rates of over 20% have far more variable mortality rates.
The poorest populations are most at risk of chronic conditions, which 
may put them at risk of dying from COVID19 [5], yet war torn coun-
tries such as Syria have not had the exponential increases in deaths 
observed in Europe and North America; suggesting that when com-
paring the effect on mortality, of different national strategies for COV-
ID-19, national obesity rates should be considered.
National mitigation measures including lockdowns and social dis-
tancing may have to extend beyond 2020/21. During this time, indi-
viduals have been advised to do mild-to-moderate exercise as it can 
be of benefit in fighting viral diseases [6]. In addition, individuals 
should be advised to lose weight (with a mild caloric restriction) to 
minimise the risk of succumbing to COVID-19.
The pressing need for this is illustrated by the analysis of risk factors 
for critical illness; patients with a BMI>40 had a far higher risk (odds 
ratio OR 6.2) of requiring hospitalisation [7]. As over one-third of 
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National targeted measures to tackle 
and prevent obesity should be intro-
duced urgently during this pandemic, 
to discourage unhealthy eating and 
support overweight individuals to 
adopt mild caloric restriction in order 
to minimise the risk of succumbing to 
COVID-19.
National death rates for Covid-19 vary 
greatly, but countries with low rates of 
obesity rates have low fatality rates. 
Higher SES (socioeconomic status) is 
associated with obesity in lower in-
come countries while the inverse is true 
in high income countries. Poorer indi-
viduals in wealthier nations are at par-
ticularly high risk of dying from COV-
ID-19, yet due to inequalities, they will 
have most difficulty in accessing essen-
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Americans, over one-fifth of Europeans and 13% of the adults in the world are obese 
[5], a very high percent of the population is at risk of severe symptomatology.
Obesity rates rise with economic development of a country [8]. Paradoxically, the re-
lationship of socioeconomic status (SES) to obesity changes, those of higher SES tend 
to be obese in lower income countries, whereas those of lower SES tend to be obese 
in high income countries. Thus, poorer individuals in wealthier nations are at par-
ticularly high risk of dying from COVID-19, yet due to inequalities, they will have 
most difficulty in accessing essential life care support. Unfortunately, interventions to 
prevent transmission have a particularly negative impact on these already impover-
ished communities. Ethnic minorities have been particularly hard hit by COVID-19, 
highlighting racial as well as economic inequalities [9].
With COVID-19, economies have been pulled into recession and unemployment rates 
have spiralled, exhausting national welfare safety nets and placing the burden onto 
the individual. Yet, those most at risk from this disease are the poorest in society, who 
have been most impacted by the mitigation strategies and those least able to access 
health care. Global health promotion strategies should emphasise the benefits of phys-
ical activity and weight loss interventions (such as those described by Brown et al 
[10]) in the fight against this pandemic, and country specific policies need to be de-
veloped quickly to support people who are most at risk.
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